EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Racial differences in postpandemic trends in prostate-specific antigen screening

Zhiyu Qian, Jameshisa Alexander, Danesha Daniels, Firas Abdollah, Alexander P Cole, Hari S Iyer, Quoc-Dien Trinh iD

JNCI Cancer Spectrum · 29.02.2024 · 8 (2)

DOI: 10.1093/jncics/pkae016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 28.03.2024. Verfasst von Zhiyu Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our study investigates the trends in prostate cancer screening amid the COVID-19 pandemic, particularly focusing on racial disparities between Black and White men. Utilizing data from the Behavioral Risk Factor Surveillance System from 2018, 2020, and 2022, we analyzed prostate-specific antigen screening rates in men aged 45-75 years. Our findings reveal initial declines in screening rates for both groups during the pandemic, with subsequent recovery; however, the pace of rebound differed statistically significantly between races. Whereas White men showed a notable increase in screening rates postpandemic, Black men’s rates recovered more slowly. This disparity underscores the impact of socioeconomic factors, health-care access, and possibly systemic biases affecting health-care delivery. Our study highlights the need for targeted interventions to address these inequalities and ensure equitable access to prostate cancer preventive care in the aftermath of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCOVID-19MaleHumansProstate-Specific AntigenEarly Detection of CancerPandemicsRace Factors

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA.
  • Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
  • Section of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

ORCID-Profile: Quoc-Dien Trinh

Zitieren

APA

Qian, Z., Alexander, J., Daniels, D., Abdollah, F., Cole, A. P., Iyer, H. S., & Trinh, Q. D. (2024). Racial differences in postpandemic trends in prostate-specific antigen screening. JNCI Cancer Spectrum, 8(2). https://doi.org/10.1093/jncics/pkae016

Vancouver

Qian Z, Alexander J, Daniels D, Abdollah F, Cole AP, Iyer HS, et al. Racial differences in postpandemic trends in prostate-specific antigen screening. JNCI Cancer Spectrum. 2024;8(2). doi:10.1093/jncics/pkae016

BibTeX
@article{Qian2024,
  author = {Qian, Zhiyu and Alexander, Jameshisa and Daniels, Danesha and Abdollah, Firas and Cole, Alexander P and Iyer, Hari S and Trinh, Quoc-Dien},
  title = {Racial differences in postpandemic trends in prostate-specific antigen screening},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  volume = {8},
  number = {2},
  doi = {10.1093/jncics/pkae016}
}
Kostenlos starten →